Microsoft launches its first mobile app for autism, the Vaccine Development Platform
Developer options: The Microsoft Vaccine development platform lets developers build apps for Microsoft’s vaccine development platform.
Microsoft announced the launch of the platform on Monday.
The platform allows developers to develop apps that run on Windows Phone, Xbox, HoloLens, HoloCore, HoloVision, HoloTouch, HoloGoo, HoloChat, and HoloLens apps, and will allow developers to build apps using a variety of platform features.
The app can also be used to test and measure vaccine development using a standardized test called a test harness, which includes a phone or tablet and an accelerometer.
The testing harness includes an embedded sensor, and a sensor on the app can be connected to the accelerometer to test its functionality.
In addition, Microsoft said the platform can be used for the testing of vaccine-related technologies, including vaccines for the human immunodeficiency virus (HIV), flu vaccines, and other vaccines.
Microsoft also announced the Windows 10 SDK for Android and iOS apps.
Microsoft said it will begin shipping the SDK for the Windows Phone 8.0 operating system to developers starting in June, but there are no plans to begin shipping it to developers in the United States yet.
The Windows 10 platform is the latest major version of the Microsoft operating system that is optimized for mobile devices, and the company said it has partnered with Apple to create a developer portal to enable developers to get started with the platform.